https://www.selleckchem.com/products/stf-31.html
Pridopidine is a novel drug that helps stabilize psychomotor function in patients with Huntington's disease (HD) by activating the cortical glutamate pathway. It promises to achieve the unmet needs of current therapies of HD without worsening other symptoms. To review the literature discussing the efficacy of pridopidine in alleviating motor symptoms and its safety in patients with HD. We searched Scopus, Web of Science, the Cochrane Library, Wiley, and PubMed for randomized controlled trials (RCTs) of pridopidine on HD. Data from eligib
Like
Comment
Share
